BRIC Hernia Repair Devices Market Outlook to 2023 Global Lupus Nephritis Market by Value, Segments,

Global Lupus Nephritis Market by Value, Segments, Disease, Region,
Analysis and Forecast to 2030
ReportsWeb.com published “Lupus Nephritis Market” from its database. The report covers the
market landscape and its growth prospects over the coming years. The report also includes a
discussion of the key vendors operating in this market.
Lupus nephritis is inflammation of the kidney that is caused by systemic lupus erythematous
(SLE). Also called lupus, SLE is an autoimmune disease where the immune system turns against
the body, affecting vital organs. While the primary cause of the disease is unknown, it is
expected that factors such as viruses, infections, pollutants, and toxic chemicals, along with
family history plays a role in causing the disease. The disease is more common in women
compared to men. Kidney damage from lupus erythematosus can vary from mild to severe. In
lupus nephritis, glomeruli or the filtering units are damaged. As a result, waste from the blood
does not get filtered. Lupus nephritis happens when lupus involves the kidneys. When the
kidneys are inflamed, they cannot function normally and can leak protein. If not controlled,
lupus nephritis can lead to kidney failure.
For more information about this report: http://www.reportsweb.com/global-lupus-nephritis-
market-industry-analysis-and-outlook
The treatment for Lupus Nephritis is based upon on its type, which is determined by the biopsy.
Since, symptoms and severity vary from person to person, treatments are individually tailored
to meet a person's particular circumstances.
The global Lupus Nephritis market is set to experience favourable growth driven by factors such
as increasing African-American population, rising health care expenditure and accelerating
economic growth. The major trends observed in the market are new drugs under pipeline for
Lupus Nephritis, increasing research grants with rising public awareness about the disease.
However, the growth of this budding market will be hindered by stringent regulations,
associated risk and high cost.
The report "Global Lupus Nephritis Market: Industry Analysis & Outlook (2021-2030)" analyses
the development of this market, with focus on the U.S, Europe and Japan markets. The major
trends, growth drivers as well as issues being faced by the market are discussed in detail in this
report. The five major players: Aurinia Pharmaceuticals Inc., Roche Holding AG, Bristol-Myers
Squibb, GlaxoSmithKline Plc. and AstraZeneca are being profiled along with their key financials